Ting Liu

Ting Liu

Auto-generated profile, based on publicly available information

Ting Liu

School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
TLTing Liu
Ting Liu
MCMinglong Chen
Minglong Chen
JFJintao Fu
Jintao Fu
YSYing Sun
Ying Sun
Chao LuChao Lu
Chao Lu
CWChuanbin Wu
Chuanbin Wu
Proteins and peptides have become a significant therapeutic modality for various diseases because of their high potency and specificity. However, the inherent properties of these drugs, such as large molecular weight, poor stability, and conformational flexibility, make them difficult to be formulated and delivered. Injection is the primary route for clinical administration of protein and peptide drugs, which usually leads to poor patient's compliance. As a portable, minimally invasive device, microneedles (MNs) can overcome the skin barrier and generate reversible microchannels for effective macromolecule permeation. In this review, we highlighted the recent advances in MNs-mediated transdermal delivery of protein and peptide drugs. Emphasis was given to the latest development in representative MNs design and fabrication. We also summarize the current application status of MNs-mediated transdermal protein and peptide delivery, especially in the field of infectious disease, diabetes, cancer, and other disease therapy. Finally, the current status of clinical translation and a perspective on future development are also provided.